These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study. Deux JF; Damy T; Rahmouni A; Mayer J; Planté-Bordeneuve V Amyloid; 2014 Dec; 21(4):246-55. PubMed ID: 25211144 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559 [TBL] [Abstract][Full Text] [Related]
6. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis. Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773 [TBL] [Abstract][Full Text] [Related]
9. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study. Ingebrigtsen A; Saeed S; Larsen TH; Reikvam H Scand J Clin Lab Invest; 2024 May; 84(3):193-201. PubMed ID: 38709651 [TBL] [Abstract][Full Text] [Related]
10. Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis. Kravchenko D; Isaak A; Zimmer S; Öztürk C; Mesropyan N; Bischoff LM; Voigt M; Ginzburg D; Attenberger U; Pieper CC; Kuetting D; Luetkens JA Eur Heart J Cardiovasc Imaging; 2024 Jun; ():. PubMed ID: 38912832 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349 [TBL] [Abstract][Full Text] [Related]
12. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222 [TBL] [Abstract][Full Text] [Related]
13. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis]. Cui Q; Yu J; Shen W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]